NHS England acknowledges concerns around anaphylaxis and highlights discussions with stakeholders to improve data collection, understanding, and research. They reference the Immunology and Allergy Clinical Reference Group, specialised allergy service specifications, and initiatives by BSACI and the Royal College of Physicians. (AI summary)
View full response
relating to allergy that require policy change or development and advise on how to best achieve improved outcomes. NHS England’s National Patient Safety Team is also working closely with the UK Fatal Anaphylaxis Registry to develop a mechanism for sharing relevant patient safety anaphylaxis incidents with them and this work is ongoing. The British Society for Allergy & Clinical Immunology (BSACI) has also recently established the Perioperative Allergy Network Steering Committee which looks to address recommendations made in the National Audit Project 6 anaphylaxis report. At the end of August 2023 they published recommendations on referral for assessment of suspected anaesthesia related allergy: Perioperative Allergy Network recommendations of suspected anaesthesia related allergy - BSACI. The BSACI should be able to provide further information on this if required. Additionally, the Royal College of Physicians Improving Quality in Allergy Services accreditation programme (IQAS) https://www.iqas.org.uk/ was set up to improve the quality of allergy services across the UK. The programme independently measures services against national standards with the aim of reducing variation across the country, promotes quality improvement through highlighting areas of best practice and areas for change and demonstrates the service's dedication to improvement, patient safety and reducing risk. The programme includes domains relating to clinical care and performance. The current IQAS standards (2019) are due to be revised in 2024 and NHS England has been assured by the IQAS clinical lead that horizon scanning means that perioperative anaphylaxis services will be front and centre of the review. The Royal College should be able to provide further information on this, should you require it. NHS England’s NSA for Specialised Immunology and Allergy and the CRG has provided assurances that they recognise the importance of the issues relating to investigation and follow up of perioperative anaphylaxis as highlighted in your Report and will be taking points raised into consideration in the development of the specialised allergy service specifications and commissioning policies. NHS England has also been in touch with our DHSC counterparts regarding their response to you, and we hope that you will hear from them shortly. I hope that this is helpful to you and please do not hesitate to contact me should you need any further information.